-
PRINCETON, NJ - Feb 7, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced its latest advances in bringing model-informed precision dosing (MIPD) to the point of care
Feb 7, 2019
-
LONDON, UNITED KINGDOM - Feb 7, 2019 -
Leading healthcare technology investors partner with Clinithink to unlock the potential of unstructured data to inform treatment decisions, identify candidates for clinical trials, and ensure appropriate reimbursement
Clinithink,
which
offers healthcare and life sciences organizations powerful clinical data insights through its patented CLiX natural language processing (NLP) platform, has secured a growth-equity investment from TT Capital Partners (TTCP) and the MSD Global Health Innovation Fund (GHI) to expand its global footprint and continue to broaden its service offering
Feb 7, 2019
-
PRINCETON, NJ - Jan 30, 2019 - The WIRB-Copernicus Group®s (WCG) Market Intelligence & Insights Division has acquired First Clinical Research LLC, organizer of the MAGI (Model Agreements & Guidelines International) Clinical Research Conference, which unifies the clinical research ecosystem by facilitating communication and the sharing of best practices among members
Jan 30, 2019
-
PRINCETON, NJ - Jan 29, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 18 of its Simcyp® Population-based Simulator
Jan 29, 2019
-
CAMBRIDGE, UK - Jan 18, 2019 - ~~Rapid Biosensor Systems (RBS), the technology company that developed a 2-minute breathalyser test for TB, can adapt its platform technology for screening of lung cancer
Jan 18, 2019
-
PRINCETON, NJ - Jan 15, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today reported that more than 90% of novel new drug approvals by the US Food and Drug Administration (FDA) in 2018 were supported by Certara software or services
Jan 15, 2019
-
SAN ANTONIO, TX, UNITED STATES - Jan 8, 2019 - SAN ANTONIO, Jan. 8, 2019 /PRNewswire/ -- Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today provided a summary of key 2018 data publications and presentations that demonstrate the clinical utility and healthcare economic benefits of its proprietary, cutting-edge technology
Jan 8, 2019
-
BRISBANE, CA, UNITED STATES - Dec 20, 2018 - BRISBANE, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announces the publication of data demonstrating the clinical utility of measuring AlloSure in repeat kidney transplant recipients in the
American Journal of Transplantation
Dec 20, 2018
-
SUFFERN, NY, UNITED STATES - Dec 20, 2018 - SUFFERN, N.Y., Dec. 20, 2018 (GLOBE NEWSWIRE) -- CDx Diagnostics today announced the publication of new data demonstrating that the addition of WATS3D (Wide Area Transepithelial Sampling with 3D Tissue Analysis) to standard targeted and random forceps biopsy (FB) markedly increases the overall detection of esophageal dysplasia (ED) by 242% and the overall detection of Barretts esophagus (BE) by 153% in patients undergoing BE screening and surveillance
Dec 20, 2018
-
PRINCETON, NJ - Dec 19, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced a new research report that investigates the potential of pharmaceutical outcomes-based contracting
Dec 19, 2018
-
ALAMEDA, CA, UNITED STATES OF AMERICA - Dec 17, 2018 - Contact: Marcia Ruggio
Global Brand Marketing Manager
m.ruggio@singulex.com
(510) 995-3859Singulex, Inc
Dec 17, 2018
-
, UK & INDIA - Dec 12, 2018 - QuantuMDx Group Limited and Molbio Diagnostics Private Limited have signed a memorandum of understanding (MoU) to explore opportunities for joint working in infectious disease diagnostics, with an initial focus on genotypic drug resistance testing for those infected with tuberculosis
Dec 12, 2018
-
SYDNEY, AUSTRALIA - Dec 10, 2018 - AusDiagnostics has CE marked a new kit for detection of haemochromatosis - a genetic disease that results in iron overload and eventually organ failure
Dec 9, 2018
-
SAN ANTONIO, TX, UNITED STATES - Dec 7, 2018 - SAN ANTONIO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Data presented this week on wire-free radar breast localization demonstrated it may be a practical approach for positive axillary lymph node localization prior to neoadjuvant chemotherapy treatment (NAT) response
Dec 7, 2018
-
PRINCETON, NJ - Dec 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of its BaseCase Toolkits, an add-on to BaseCase Interactive which helps pharmaceutical and medical device field representatives better manage and utilize their resources for use during customer presentations
Dec 5, 2018
-
SPRING HOUSE, PA, UNITED STATES - Dec 3, 2018 - Cognizance Biomarkers, LLC, a wholly-owned subsidiary of Evogen, Inc., a leader in proteomic and genomic-based testing for improved diagnosis and treatment of neurological disorders, today reported that a study1 being presented at the 2018 Annual Meeting of the American Epilepsy Society (AES) shows its blood-based neuroinflammatory biomarker test and algorithm can accurately distinguish epileptic seizures (ES) from psychogenic nonepileptic seizures (PNES)
Dec 2, 2018
-
PRINCETON, NJ - Nov 28, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2
Nov 28, 2018
-
CAMBRIDGE, UK - Nov 27, 2018 - Prostate cancer is the most common cancer in men, with 1 in 8 diagnosed at some point in their lives
Nov 27, 2018
-
AUCKLAND CITY, NEW ZEALAND - Nov 15, 2018 -
VIB Accelerates Therapeutic Biologics Discovery with Geneious Biologics
AUCKLAND, NZ - November 12, 2018 - Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been chosen by the VIB (a Life Sciences Research Institute in Belgium) to support therapeutic biologics discovery at its Discovery Sciences group
Nov 15, 2018
-
BRISBANE, CA - Nov 14, 2018 - CareDx Announces Pricing of Public Offering of Common StockBRISBANE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc
Nov 14, 2018